Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.46 |
| ▸ | POLA1 | P09884 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17792042 | 0.86 | CHEK1 (0.46) | CTDSP1CYP1A2CYP2A6HSD17B1HSD17B2 | |
| SCHEMBL19668430 | 0.84 | HSD17B1 (0.53) | CTDSP1CYP1A2HSD17B1HSD17B2POLA1 | |
| SCHEMBL26447355 | 0.84 | CHEK1 (0.45) | CTDSP1CYP1A2CYP2A6HSD17B1HSD17B2 | |
| SCHEMBL772927 | 0.83 | HSD17B1 (0.59) | CTDSP1CYP1A2CYP2A6HSD17B1HSD17B2 | |
| SCHEMBL29352754 | 0.77 | CTDSP1 (0.63) | CTDSP1CYP1A2HSD17B1HSD17B2GRIN2D | |
| SCHEMBL29738648 | 0.77 | CTDSP1 (0.63) | CTDSP1CYP1A2HSD17B1HSD17B2GRIN2D | |
| SCHEMBL29616 | 0.77 | CTDSP1 (0.63) | CTDSP1CYP1A2HSD17B1HSD17B2GRIN2D | |
| SCHEMBL6561452 | 0.77 | CYP2A6 (0.58) | CYP1A2CYP2A6MAPK1TSHRHSD17B10 | |
| SCHEMBL30366567 | 0.77 | CYP2A6 (0.58) | CYP1A2CYP2A6MAPK1TSHRHSD17B10 | |
| SCHEMBL19460401 | 0.76 | CYP2A6 (0.47) | CTDSP1CYP1A2CYP2A6HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667474-A2 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | Samsung Display Co., Ltd. (KR) | 2025-12-24 | — | — | EP | disclosed |
| EP-3909946-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024208207-A1 | DISUBSTITUTED NAPHTHALENE COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 拜西欧斯（北京）生物技术有限公司 | 2024-10-10 | — | — | WO | disclosed |
| US-20240270758-A1 | PYRIDINO-OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | ZHEJIANG GENFLEET THERAPEUTICS CO., LTD. (CN) | 2024-08-15 | — | — | US | disclosed |
| EP-4332105-A1 | PYRIDINO- OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Genfleet Therapeutics (Shanghai) Inc. (CN) | 2024-03-06 | — | — | EP | disclosed |
| CN-117222650-A | Pyridine or pyrimido-ring compound, preparation method and medical application thereof | 劲方医药科技(上海)有限公司 | 2023-12-12 | — | — | CN | disclosed |
| EP-4286491-A2 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | Samsung Display Co., Ltd. (KR) | 2023-12-06 | — | — | EP | disclosed |
| CN-115703747-A | Organic compound having spirofluorene structure for light emitting device, organic electroluminescent device | 北京鼎材科技有限公司 | 2023-02-17 | — | — | CN | disclosed |
| US-20220416174-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
| US-20220416174-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-12-29 | — | — | US | disclosed |
| WO-2006105193-A2 | PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105260-A1 | ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105261-A1 | CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-4061642-A | AZO DYE INTERMEDIATES | CASSELLA FARBWERKE MAINKUR AG (DT) | 1977-12-06 | — | — | US | disclosed |
| US-3985731-A | MICROBIOCIDES, MOTOR ACTIVITY INDUCERS, CNS STIMULANTS | E. R. SQUIBB & SONS, INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3980659-A | INSECTICIDES, INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-09-14 | — | — | US | disclosed |
| US-3956294-A | AZO DYES, PESTICIDES, ANALEPTICS, ANALGESICS, DIURETICS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3954782-A | 2,6-Hydrazino-3-pyridine carboxyamides | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3947463-A | Certain 2-amino-nicotinonitrile derivatives | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-30 | — | — | US | disclosed |
| US-3946024-A | INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270758-A1 | PYRIDINO-OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | KRAS, NRAS, BRAF | CTDSP1 933/4885CYP1A2 1592/4885CYP2A6 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.